SGH
IDXX icon

Sivik Global Healthcare’s Idexx Laboratories IDXX Stock Holding History

Sivik Global Healthcare’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17,500
Closed -$2.72M – 76
2017
Q3 		$2.72M Buy
+17,500
New +$2.77M 0.93% 39
2017
Q1 		– Sell
-20,000
Closed -$2.35M – 65
2016
Q4 		$2.35M Buy
+20,000
New +$2.28M 1.12% 35

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sivik Global Healthcare's IDXX Position: Q4 2017 in Review

Sivik Global Healthcare sold out of Idexx Laboratories (IDXX) in Q4 2017, closing a stake of 17,500 shares — an estimated $2.72M sold.

Sivik Global Healthcare first reported a position in IDXX in Q4 2016 and held it in 2 quarters. The position peaked at $2.72M in Q3 2017. 613 funds tracked by Wall St. Rank hold IDXX as of Q4 2017.

  • Sivik Global Healthcare reported no remaining Idexx Laboratories position as of Q4 2017 after selling out during the quarter.
  • Sivik Global Healthcare sold 17,500 Idexx Laboratories shares in Q4 2017, an estimated $2.72M.
  • Sivik Global Healthcare first reported a position in Idexx Laboratories in Q4 2016 and held it in 2 quarters.
  • Sivik Global Healthcare's Idexx Laboratories position peaked at $2.72M in Q3 2017.
  • 613 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2017.

Based on Sivik Global Healthcare's 13F filing for Q4 2017, filed 8 Feb 2018.